HomeCompareNPRRF vs BTI

NPRRF vs BTI: Dividend Comparison 2026

NPRRF yields 1.90% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BTI wins by $15.3K in total portfolio value
10 years
NPRRF
NPRRF
● Live price
1.90%
Share price
$9.96
Annual div
$0.19
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.5K
Annual income
$214.67
Full NPRRF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — NPRRF vs BTI

📍 BTI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNPRRFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NPRRF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NPRRF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NPRRF
Annual income on $10K today (after 15% tax)
$161.38/yr
After 10yr DRIP, annual income (after tax)
$182.47/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, BTI beats the other by $2,199.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NPRRF + BTI for your $10,000?

NPRRF: 50%BTI: 50%
100% BTI50/50100% NPRRF
Portfolio after 10yr
$30.1K
Annual income
$1,508.48/yr
Blended yield
5.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

NPRRF
No analyst data
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NPRRF buys
0
BTI buys
0
No recent congressional trades found for NPRRF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNPRRFBTI
Forward yield1.90%5.40%
Annual dividend / share$0.19$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3%
Portfolio after 10y$22.5K$37.8K
Annual income after 10y$214.67$2,802.29
Total dividends collected$2.0K$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NPRRF vs BTI ($10,000, DRIP)

YearNPRRF PortfolioNPRRF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$10,890$189.86$11,301$601.08$411.00BTI
2$11,845$193.23$12,799$706.58$954.00BTI
3$12,871$196.43$14,527$832.38$1.7KBTI
4$13,971$199.48$16,527$982.75$2.6KBTI
5$15,152$202.37$18,846$1,162.95$3.7KBTI
6$16,418$205.11$21,545$1,379.49$5.1KBTI
7$17,774$207.70$24,694$1,640.41$6.9KBTI
8$19,229$210.16$28,378$1,955.69$9.1KBTI
9$20,787$212.48$32,702$2,337.79$11.9KBTI
10$22,457$214.67$37,794$2,802.29$15.3KBTI

NPRRF vs BTI: Complete Analysis 2026

NPRRFStock

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses. The company's Medical Device business develops, manufactures, and sells medical equipment for injection-infusion and dialysis treatment, and products related to diabetes and cell cultures, as well as the sale of artificial organ-related products. Its Pharmaceutical business provides pharmaceutical combination products, including dual chamber bags, pre-filled syringes, and half-type kits; and contract manufacturing services for orally administered drugs, injectables, and external preparations, as well as logistic and distribution services. The company's Pharma Packaging business offers glass products and other comprehensive pharmaceutical packaging, such as glass vials, ampoules, syringes, and cartridges; glass tubes; glass bulbs for vacuum flasks; and other parts of pharmaceutical packaging, such as rubber plugs. Its Other business provides thermostable enzymes for clinical chemistry. The company also offers business management services. Nipro Corporation serves customers in Japan, the Americas, Europe, and rest of Asia. The company was founded in 1947 and is headquartered in Osaka, Japan.

Full NPRRF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this NPRRF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NPRRF vs SCHDNPRRF vs JEPINPRRF vs ONPRRF vs KONPRRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.